Similar articles

• Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis.

  Ho KM, Ismail H. Ho KM, et al. Anaesth Intensive Care. 2003 Oct;31(5):529-37. doi: 10.1177/0310057X0303100507. Anaesth Intensive Care. 2003. PMID: 14601276
• Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties.

  Ido K, Neo M, Asada Y, Kondo K, Morita T, Sakamoto T, Hayashi R, Kuriyama S. Ido K, et al. Arch Orthop Trauma Surg. 2000;120(9):518-20. doi: 10.1007/s004029900132. Arch Orthop Trauma Surg. 2000. PMID: 11011672 Clinical Trial.
• The Michigan Experience with Safety and Effectiveness of Tranexamic Acid Use in Hip and Knee Arthroplasty.

  Hallstrom B, Singal B, Cowen ME, Roberts KC, Hughes RE. Hallstrom B, et al. J Bone Joint Surg Am. 2016 Oct 5;98(19):1646-1655. doi: 10.2106/JBJS.15.01010. J Bone Joint Surg Am. 2016. PMID: 27707851
• Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.

  Xie J, Hu Q, Huang Q, Ma J, Lei Y, Pei F. Xie J, et al. Thromb Res. 2017 May;153:28-36. doi: 10.1016/j.thromres.2017.03.009. Epub 2017 Mar 10. Thromb Res. 2017. PMID: 28319822 Review.
• Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.

  Watts CD, Pagnano MW. Watts CD, et al. J Bone Joint Surg Br. 2012 Nov;94(11 Suppl A):8-10. doi: 10.1302/0301-620X.94B11.30618. J Bone Joint Surg Br. 2012. PMID: 23118371 Review.